Mereo BioPharma Group PLC ADR (MREO) Live Share Price, Invest From India

Mereo BioPharma Group PLC ADR Stock Performance

as on April 28, 2026 at 3:10 am IST

Day's High
$0.28
Day's Price Range
$0.30
$0.28
7.14%
Upside
52 Week's Low
52 Week's High
$0.20
52-Week Price Range
$3.05
$0.28
28.57%
Downside
989.29%
Upside

Mereo BioPharma Group PLC ADR share price movements today

Previous Close: $0.29
Open: $0.28
Volume: 950.9K
Day's Low - High: $0.28 - $0.30
52 Week Low - High: $0.20 - $3.05

Mereo BioPharma Group PLC ADR Historical Returns

1 Month Return: -11.88 %
3 Month Return: -38.55 %
1 Year Return: -88.4 %
3 Year Return: -75.83 %
5 Year Return: -91.83 %

Mereo BioPharma Group PLC ADR Stock Fundamentals & Key Indicators

Check Mereo BioPharma Group PLC ADR market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$46.6M

EPS (TTM)

-0.028

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-37.9M

Revenue (TTM)

500.0K

Profit Margin

0.00%

Return On Equity TTM

-82.21%

Mereo BioPharma Group PLC ADR vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Mereo BioPharma Group PLC ADR with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Mereo BioPharma Group PLC ADR	BUY	$46.6M	-91.83%	NA	0.00%
Alnylam Pharmaceuticals Inc	BUY	$40.8B	116.23%	131.7	8.45%
Vertex Pharmaceuticals Inc	BUY	$109.5B	99.64%	28.1	32.94%
BeiGene, Ltd.	NA	$33.4B	NA	121.78	5.37%
Regeneron Pharmaceuticals Inc	BUY	$79.5B	52.82%	18.11	31.41%

Stock Returns calculator for Mereo BioPharma Group PLC ADR Stock including INR - Dollar returns

The Mereo BioPharma Group PLC ADR stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Mereo BioPharma Group PLC ADR investment value today

Current value as on today

₹12,387

Returns

-₹87,613

(-87.61%)

Returns from Mereo BioPharma Group PLC ADR Stock

-₹88,800 (-88.8%)

Dollar Impact

₹1,187 (+1.19%)

Analyst Recommendation on Mereo BioPharma Group PLC ADR Stock

Based on 10 analysts

BUY

90.00%

Buy

10.00%

Hold

0.00%

Sell

Based on 10 analysts, 90% of analysts recommend a 'BUY' rating for Mereo BioPharma Group PLC ADR. Average target price of $1.77

Mereo BioPharma Group PLC ADR Share Price Target

Get share price movements and forecasts by analysts on Mereo BioPharma Group PLC ADR.

What analysts predicted

84.18%UPSIDE

Target Price

$1.77

Current Price

$0.28

Analyzed by

10 Analysts

Target

$1.77

Mereo BioPharma Group PLC ADR target price $1.77, a slight upside of 84.18% compared to current price of $0.28. According to 10 analysts rating.

Mereo BioPharma Group PLC ADR Stock’s Investor Sentiment and Interest

Search interest for Mereo BioPharma Group PLC ADR Stock has decreased by -62% in the last 30 days, reflecting a downward trend in search activity.

Time period: March 28, 2026 to April 27, 2026

Change:-62% versus previous 30 day period

Mereo BioPharma Group PLC ADR Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	0	1	-	-	-	1	-	0	-	-
Gross Profit	0	1	0	0	0	0	0	0	0	0
Operating Income	-6	-7	-9	-12	-9	-15	-11	-10	-10	-8
EBITDA	-7	-9	-8	-11	-14	-6	-12	-14	-9	-6
Interest Expense	0	4	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-6	-9	-8	-12	-15	-7	-12	-14	-7	-9
Income Tax Expense	0	0	0	0	-15	0	-	-	-	0
Net Income	-6	-9	-8	-12	-15	-6	-12	-14	-7	-7
Net Profit Margin	-1229.72%	-910.90%	0.00%	0.00%	0.00%	-655.92%	0.00%	-2923.20%	0.00%	0.00%

Mereo BioPharma Group PLC ADR Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-4	-	0	0	65	1	10	-	0
Gross Profit	-30	-50	-28	-2	-2	33	0	7	-1	0
Operating Income	-36	-45	-35	-50	-48	-28	-53	-28	-47	-40
EBITDA	-38	-44	-34	-44	-203	25	-39	-26	-40	-39
Interest Expense	0	1	2	3	6	5	3	2	1	0
Depreciation	-	0	0	1	1	0	0	1	1	1
Income Before Tax	-33	-46	-37	-52	-213	19	-44	-29	-43	-43
Income Tax Expense	-5	-8	-5	-8	-3	2	-2	0	0	-1
Net Income	-35	-52	-40	-58	-281	22	-51	-29	-43	-41
Net Profit Margin	0.00%	1180.99%	0.00%	36435.94%	-53391.63%	34.90%	-2795.09%	-294.66%	0.00%	-8375.60%

Mereo BioPharma Group PLC ADR Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-9	-8	-12	-14	-7	-12	-14	-7	-7
Operating Cash Flow	-6	-7	-7	-7	-9	-8	-7	-7	-7
Investing Cash Flow	0	0	0	0	0	0	0	0	0
Financing Cash Flow	4	-	46	0	0	0	0	-	0
Change in Cash	-5	-8	38	-6	-10	-7	-6	-7	-7

Mereo BioPharma Group PLC ADR Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-46	-37	-53	-226	19	-42	-29	-43	-41
Operating Cash Flow	-32	-23	-60	-38	-7	-48	-21	-32	-30
Investing Cash Flow	-3	0	56	2	0	1	0	0	0
Financing Cash Flow	33	-2	-7	47	104	0	7	46	0
Change in Cash	-3	-25	-11	9	95	-59	-10	12	-28

Global Institutional Holdings in Mereo BioPharma Group PLC ADR

Funds	Holdings
Schonfeld Strategic Advisors LLC	3.82%
Bank of America Corp	0.27%
HHG PLC	10.21%
Clearline Capital LP	2.27%
EntryPoint Capital LLC	0.25%

See all

Insights on Mereo BioPharma Group PLC ADR

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Regeneron Pharmaceuticals, Inc. has given 24.7% return, outperforming this stock by 113.1%
NO EFFECT
Against Peers
In the last 3 years, Mereo Biopharma Group PLC has experienced a drawdown of -75.8%, however Alnylam Pharmaceuticals, Inc. resisted the overall trend and outperformed by 70.7%
NEGATIVE IMPACT
Price Dip
In the last 7 days, MREO stock has moved down by -13.9%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 1.06M → 500.0K (in $), with an average decrease of 53.0% per quarter
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, -7.02M → -7.35M (in $), with an average decrease of 4.7% per quarter

About Mereo BioPharma Group PLC ADR

Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of rare diseases in the United Kingdom and the United States. The company develops Setrusumab, an antibody for the treatment of osteogenesis imperfecta; Alvelestat, an oral small molecule that is in Phase II clinical trial to treat Alpha-1 anti-trypsin deficiency associated lung disease; and Vantictumab, an anti-FZD monoclonal antibody for the treatment of autosomal dominant osteopetrosis type 2. It also develops Leflutrozole, an oral aromatase inhibitor, which is in Phase 2 trials for use in the treatment of hypogonadotropic hypogonadism; Navicixizumab, which has completed Phase 1b clinical trials for the treatment of the late line ovarian cancer; Etigilimab, an IgG1 monoclonal antibody which binds to the human TIGIT receptor on immune cells for the Treatment of advanced solid tumors; and Acumapimod, a p38 MAP kinase inhibitor that is in Phase II clinical trials to treat acute exacerbations of chronic obstructive pulmonary disease. The company has a license agreement with Feng Biosciences for the development and commercialization of navicixizumab; license agreement with ReproNovo for the development and commercialization of leflutrozole; and licensing agreement with AstraZeneca. Mereo BioPharma Group plc was incorporated in 2015 and is headquartered in London, United Kingdom.

Organisation	Mereo BioPharma Group PLC ADR
Headquarters	One Cavendish Place, London, United Kingdom, W1G 0QF
Industry	Biotechnology
CEO	Dr. Denise Vera Scots-Knight Ph.D.
E-voting on shares	Click here to vote

Key Management of Mereo BioPharma Group PLC ADR

Name	Title
Mr. Charles Edward Sermon	Co-Founder, General Counsel, Business Development & Company Secretary
Ms. Christine Fox CPA	Chief Financial Officer
Dr. John A. Lewicki Ph.D.	Chief Scientific Officer
Dr. Jackie Parkin	Senior VP & Therapeutic Head
Ms. Alexandra Hughes-Wilson	Chief of Patient Access & Commercial Planning
Mr. Bo Kara	Senior VP and Head of Pharmaceutical Development & CMC
Dr. Denise Vera Scots-Knight Ph.D.	Co-Founder, CEO & Executive Director

FAQs

What is Mereo BioPharma Group PLC ADR share price today?

Mereo BioPharma Group PLC ADR share price today is $0.28 as on April 27, 2026 at 9:40 pm IST. Mereo BioPharma Group PLC ADR share today touched a day high of $0.3 and a low of $0.28.

What is the 52 week high and 52 week low for Mereo BioPharma Group PLC ADR share?

Mereo BioPharma Group PLC ADR share touched a 52 week high of $3.05 on July 9, 2025 and a 52 week low of $0.2 on December 29, 2025. Mereo BioPharma Group PLC ADR stock price today i.e. April 27, 2026 at 9:40 pm IST is trending at $0.28,which is 90.82% down from its 52 week high and 40.00% up from its 52 week low.

What is Mereo BioPharma Group PLC ADR's market capitalisation today?

Mereo BioPharma Group PLC ADR market capitalisation is $0.00T as on April 27, 2026 at 9:40 pm IST.

How to invest in Mereo BioPharma Group PLC ADR Stock (MREO) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Mereo BioPharma Group PLC ADR on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Mereo BioPharma Group PLC ADR Shares that will get you 5.3571 shares as per Mereo BioPharma Group PLC ADR share price of $0.28 per share as on April 27, 2026 at 9:40 pm IST.

What is the minimum amount required to buy Mereo BioPharma Group PLC ADR Stock (MREO) from India?

Indian investors can start investing in Mereo BioPharma Group PLC ADR (MREO) shares with as little as ₹94.19 or $1 (as of April 27, 2026 at 9:40 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹941.90 in Mereo BioPharma Group PLC ADR stock (as per the Rupee-Dollar exchange rate as on April 27, 2026 at 9:40 pm IST). Based on Mereo BioPharma Group PLC ADR share’s latest price of $0.28 as on April 27, 2026 at 9:40 pm IST, you will get 35.7143 shares of Mereo BioPharma Group PLC ADR. Learn more about fractional shares .

What are the returns that Mereo BioPharma Group PLC ADR has given to Indian investors in the last 5 years?

Mereo BioPharma Group PLC ADR stock has given -91.83% share price returns and 26.36% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?